Company / Return on Equity (ROE)
Nutex Health, Inc. Return on Equity (ROE) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
21.5%
FY2025
5-year range
-443.1% / 115.7%
FY2021-FY2025
Trend
-45.4%
vs FY2024
Sector context
#73 of 326
Industrials
What the data says
Nutex Health, Inc.'s return on equity (roe) of 21.5% is higher than 78% of companies in the Industrials sector (FY2025). Return on Equity (ROE) has fluctuated over the past 6 years, ranging from -443.1% in FY2022 to 115.7% in FY2021.
Based on SEC 10-K filings.
21.5% in FY2025 with a 3-year CAGR of +464.6%. Top quartile in the Industrials sector.
Improved from -74.5% to 21.5% over the past 2 years.
Industrials sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +464.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
+114.0% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 45.4% year-over-year.
- Currently 11.4pp above the Industrials sector average.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- Strong profit margin: 40.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 21.5% | -45.4% |
| FY2024 | 39.3% | +152.8% |
| FY2023 | -74.5% | +83.2% |
| FY2022 | -443.1% | -483.1% |
| FY2021 | 115.7% | - |
| FY2020 | - | - |
| FY2019 | -382.9% | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026